ANTONIO IGNACIO
FERNÁNDEZ ORTIZ
Profesor asociado de Ciencias de la Salud
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro Nacional de Investigaciones Cardiovasculares Carlos III (68)
2024
-
Apolipoprotein E-ϵ2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study
Circulation Research, Vol. 134, Núm. 4, pp. 411-424
-
Association between subclinical atherosclerosis burden and unrecognized myocardial infarction detected by cardiac magnetic resonance in middle-aged low-risk adults
European Heart Journal Cardiovascular Imaging, Vol. 25, Núm. 7, pp. 968-975
-
Unidirectional association of clonal hematopoiesis with atherosclerosis development
Nature Medicine
2023
-
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis
Diabetes Care, Vol. 46, Núm. 11, pp. 2050-2057
-
Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years
Journal of the American College of Cardiology, Vol. 82, Núm. 22, pp. 2069-2083
-
Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis
Cardiovascular Diabetology, Vol. 22, Núm. 1
-
Invasively managed acute coronary syndrome in octogenarian patients: a retrospective cohort study
REC: CardioClinics, Vol. 58, Núm. 1, pp. 43-54
-
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study
The Lancet Healthy Longevity, Vol. 4, Núm. 9, pp. e487-e498
-
Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study
European heart journal, Vol. 44, Núm. 29, pp. 2698-2709
2022
-
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial
European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330
-
Bone marrow activation in response to metabolic syndrome and early atherosclerosis
European Heart Journal, Vol. 43, Núm. 19, pp. 1809-1828
-
Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial
European heart journal, Vol. 43, Núm. 38, pp. 3732-3745
-
New 3-Dimensional Volumetric Ultrasound Method for Accurate Quantification of Atherosclerotic Plaque Volume
JACC: Cardiovascular Imaging, Vol. 15, Núm. 6, pp. 1124-1135
-
Sex differences in treatment strategy for coronary artery aneurysms: Insights from the international Coronary Artery Aneurysm Registry
Netherlands Heart Journal, Vol. 30, Núm. 6, pp. 328-334
-
Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis
eBioMedicine, Vol. 76
2021
-
Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes
Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791
-
Progression of Early Subclinical Atherosclerosis (PESA) Study: JACC Focus Seminar 7/8
Journal of the American College of Cardiology, Vol. 78, Núm. 2, pp. 156-179
-
Subclinical Atherosclerosis and Brain Metabolism in Middle-Aged Individuals: The PESA Study
Journal of the American College of Cardiology, Vol. 77, Núm. 7, pp. 888-898
-
Triglycerides and Residual Atherosclerotic Risk
Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041
2020
-
Association Between Body Size Phenotypes and Subclinical Atherosclerosis
The Journal of clinical endocrinology and metabolism, Vol. 105, Núm. 12